252 related articles for article (PubMed ID: 26410743)
41. Neural bases of impulse control disorders in Parkinson's disease: A systematic review and an ALE meta-analysis.
Santangelo G; Raimo S; Cropano M; Vitale C; Barone P; Trojano L
Neurosci Biobehav Rev; 2019 Dec; 107():672-685. PubMed ID: 31586557
[TBL] [Abstract][Full Text] [Related]
42. Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities.
Biundo R; Formento-Dojot P; Facchini S; Vallelunga A; Ghezzo L; Foscolo L; Meneghello F; Antonini A
J Neurol Sci; 2011 Nov; 310(1-2):64-9. PubMed ID: 21862438
[TBL] [Abstract][Full Text] [Related]
43. Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study.
Pettorruso M; Martinotti G; Fasano A; Loria G; Di Nicola M; De Risio L; Ricciardi L; Conte G; Janiri L; Bentivoglio AR
Psychiatry Res; 2014 Feb; 215(2):448-52. PubMed ID: 24373553
[TBL] [Abstract][Full Text] [Related]
44. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease.
Westermann B; Wattendorf E; Schwerdtfeger U; Husner A; Fuhr P; Gratzl O; Hummel T; Bilecen D; Welge-Lüssen A
J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):19-24. PubMed ID: 17519323
[TBL] [Abstract][Full Text] [Related]
45. Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco.
El Otmani H; Mouni FZ; Abdulhakeem Z; Attar Z; Rashad L; Saali I; El Moutawakil B; Rafai MA; Slassi I; Nadifi S
Rev Neurol (Paris); 2019 Apr; 175(4):233-237. PubMed ID: 30935674
[TBL] [Abstract][Full Text] [Related]
46. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
[TBL] [Abstract][Full Text] [Related]
47. [Predictors and modifiers of impulse control disorders in Parkinson`s disease].
Sapronova MR; Shnayder NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):145-156. PubMed ID: 28635753
[TBL] [Abstract][Full Text] [Related]
48. Impaired corticostriatal connectivity in impulse control disorders in Parkinson disease.
Carriere N; Lopes R; Defebvre L; Delmaire C; Dujardin K
Neurology; 2015 May; 84(21):2116-23. PubMed ID: 25925985
[TBL] [Abstract][Full Text] [Related]
49. Integrating genetic and clinical data to predict impulse control disorders in Parkinson's disease.
Jesús S; Periñán MT; Cortés C; Buiza-Rueda D; Macías-García D; Adarmes A; Muñoz-Delgado L; Labrador-Espinosa MÁ; Tejera-Parrado C; Gómez-Garre MP; Mir P
Eur J Neurol; 2021 Feb; 28(2):459-468. PubMed ID: 33051953
[TBL] [Abstract][Full Text] [Related]
50. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory control dysfunction in parkinsonian impulse control disorders.
Meyer GM; Spay C; Beliakova A; Gaugain G; Pezzoli G; Ballanger B; Boulinguez P; Cilia R
Brain; 2020 Dec; 143(12):3734-3747. PubMed ID: 33320929
[TBL] [Abstract][Full Text] [Related]
52. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.
Bogerts B; Meertz E; Schönfeldt-Bausch R
Arch Gen Psychiatry; 1985 Aug; 42(8):784-91. PubMed ID: 4015323
[TBL] [Abstract][Full Text] [Related]
53. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study.
Ihle J; Artaud F; Bekadar S; Mangone G; Sambin S; Mariani LL; Bertrand H; Rascol O; Durif F; Derkinderen P; Scherzer C; Elbaz A; Corvol JC; ; ; ; ; ; ; ;
Parkinsonism Relat Disord; 2020 Jun; 75():30-33. PubMed ID: 32450545
[TBL] [Abstract][Full Text] [Related]
54. The Subthalamic Nucleus, Limbic Function, and Impulse Control.
Rossi PJ; Gunduz A; Okun MS
Neuropsychol Rev; 2015 Dec; 25(4):398-410. PubMed ID: 26577509
[TBL] [Abstract][Full Text] [Related]
55. Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study.
Verger A; Klesse E; Chawki MB; Witjas T; Azulay JP; Eusebio A; Guedj E
Hum Brain Mapp; 2018 Aug; 39(8):3178-3186. PubMed ID: 29635851
[TBL] [Abstract][Full Text] [Related]
56. Prefrontal and hippocampal atrophy using 7-tesla magnetic resonance imaging in patients with Parkinson's disease.
Oh BH; Moon HC; Kim A; Kim HJ; Cheong CJ; Park YS
Acta Radiol Open; 2021 Feb; 10(2):2058460120988097. PubMed ID: 33786201
[TBL] [Abstract][Full Text] [Related]
57. Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders.
Marques A; Roquet D; Matar E; Taylor NL; Pereira B; O'Callaghan C; Lewis SJG
J Neurol; 2021 Sep; 268(9):3371-3380. PubMed ID: 33709218
[TBL] [Abstract][Full Text] [Related]
58. Dopaminergic influences on risk preferences of Parkinson's disease patients.
Kobayashi S; Asano K; Matsuda N; Ugawa Y
Cogn Affect Behav Neurosci; 2019 Feb; 19(1):88-97. PubMed ID: 30306414
[TBL] [Abstract][Full Text] [Related]
59. Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies.
Martini A; Tamburin S; Biundo R; Weis L; Antonini A; Pizzolo C; Leoni G; Chimenton S; Edelstyn NMJ
Parkinsonism Relat Disord; 2020 Sep; 78():165-177. PubMed ID: 32927414
[TBL] [Abstract][Full Text] [Related]
60. Clinical spectrum of impulse control disorders in Parkinson's disease.
Weintraub D; David AS; Evans AH; Grant JE; Stacy M
Mov Disord; 2015 Feb; 30(2):121-7. PubMed ID: 25370355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
